Quarterly report [Sections 13 or 15(d)]

Stockholders’ Equity and Earnings per Share

v3.26.3
Stockholders’ Equity and Earnings per Share
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Stockholders’ Equity and Earnings per Share

Note 13: Stockholders’ Equity and Earnings per Share

 

Common Stock

 

As of September 30, 2026 and December 31, 2025, the total number of authorized shares of common stock was 190,000,000.

 

As of September 30, 2026 and December 31, 2025, there were 62,259,654 and 54,857,000 shares of common stock outstanding, respectively.

 

During the nine months ended September 30, 2026, the Company issued 2,712,865 shares of common stock for services, which included 2,424,146 shares of common stock in connection with immediately vested restricted stock units (RSUs) granted to consultants. During the nine months ended September 30, 2025, the Company issued 226,733 shares of common stock for services in connection with immediately vested restricted stock units (RSUs) granted to consultants.

 

During the nine months ended September 30, 2026, the Company issued 159,382 shares of common stock to employees and board members in connection with vested restricted stock units (RSUs), net of shares withheld for tax obligations, consisting of 150,631 shares related to RSUs that vested during the current period and 8,751 shares related to RSUs that vested in prior periods.

 

During the nine months ended September 30, 2025, the Company issued 182,987 shares of common stock to employees and board members in connection with vested restricted stock units (RSUs), net of shares withheld for tax obligations, consisting of 173,390 shares related to RSUs that vested during the current period and 9,597 shares related to RSUs that vested in prior periods.

 

On November 18, 2025, the Company entered into an agreement to engage in a transaction under Section 3(a)(10) of the Securities Act with CCI, to settle an aggregate of $1.0 million of outstanding accounts payable in exchange for issuing 1,695,072 shares of common stock. Under the terms of the agreement, CCI makes payments to the Company’s vendors in cash and, in exchange, the Company issues shares of common stock to CCI. The settlement was valued at 1.75 shares of common stock per $1 of accounts payable, pursuant to the terms of the agreement. The transaction was approved by a court after a public hearing on the fairness of the terms and conditions. During the nine months ended September 30, 2026, the Company settled $0.6 million of accounts payable and issued an aggregate of 977,360 shares of common stock to CCI. During the nine months ended September 30, 2026, the Company recognized a loss of $0.1 million on the settlement, representing the difference between the carrying value of liabilities extinguished and the fair value of shares issued, included in Other Income (Expense), net, on the Company’s condensed consolidated statements of operations. The transaction was carried out in stages and completed in the first quarter of 2026.

 

On April 8, 2026, the Company entered into a new agreement to settle an additional $1.1 million of outstanding accounts payable under Section 3(a)(10) of the Securities Act with CCI, in exchange for issuing 2,001,797 shares of common stock, and to settle additional obligations up to $0.3 million in exchange for issuing 551,250 shares of common stock. The terms were consistent with the original arrangement. The settlement arrangement was carried out in stages and completed in the second quarter of 2026. During the nine months ended September 30, 2026, the Company recognized a loss of $0.6 million on the settlement, representing the difference between the carrying value of liabilities extinguished and the fair value of shares issued, included in Other Income (Expense), net, on the Company’s condensed consolidated statements of operations.

 

On June 16, 2026, the Company issued 1,000,000 shares of common stock upon the cash exercise of outstanding warrants at an exercise price of $0.57 per share, resulting in gross proceeds of approximately $0.6 million. The shares were issued in accordance with the terms of the underlying warrant agreements.

 

Preferred Stock

 

The Company has 10,000,000 shares of preferred stock authorized with a par value of $0.001 per share including 9,644,000 shares of undesignated preferred stock, 6,000 shares designated as 0% Series A Convertible Preferred Stock, 50,000 shares designated as Series C Preferred Stock, and 300,000 shares designated as Series D Participating Preferred Stock. The board of directors is authorized, subject to any limitations prescribed by law, without further vote or action by our stockholders, to issue from time-to-time shares of preferred stock in one or more series. Each series of preferred stock will have such number of shares, designations, preferences, voting powers, qualifications and special or relative rights or privileges as shall be determined by the board of directors, which may include, among others, dividend rights, voting rights, liquidation preferences, conversion rights and preemptive rights.

 

On July 1, 2026, the Company entered into a Preferred Stock Rights Agreement (the “Rights Agreement”) with VStock Transfer, LLC, as rights agent. In connection with the Rights Agreement, the Board of Directors declared a dividend distribution of one right (a “Right”) for each outstanding share of our common stock, payable to stockholders of record as of the close of business on July 13, 2026. In general terms, the Rights Agreement imposes significant dilution upon any person or group (other than the Company and certain other exempt persons) that is or becomes the beneficial owner of ten percent (10%) or more of the Company’s common stock without the prior approval of the Board of Directors. Each Right entitles its registered holder, upon the occurrence of certain triggering events, to purchase from the Company one one-thousandth of a share of Series D Participating Preferred Stock at a purchase price of $3.75 per one one-thousandth of a share, subject to adjustment. The Rights become exercisable only if a person or group acquires, or commences a tender or exchange offer that would result in, beneficial ownership of 10% or more of our outstanding common stock without the approval of the Board of Directors, subject to certain exceptions. The Rights are redeemable by the Board of Directors at a price of $0.001 per Right at any time prior to the earlier of the time the Rights become exercisable and their final expiration, and will expire at the close of business on June 29, 2027, unless earlier redeemed or exchanged. The Board also adopted amendments to our Bylaws that, among other things, divide the Board of Directors into two classes with staggered terms, eliminate the ability of stockholders to act by written consent, provide that special meetings of stockholders may be called only by the Board of Directors, establish advance notice procedures for stockholder nominations of directors and other stockholder proposals, require the affirmative vote of the holders of at least two-thirds of the voting power of our outstanding stock to remove a director, and designate an exclusive forum for certain legal proceedings.

 

In connection with the Rights Agreement, the Company filed with the Secretary of State of the State of Nevada a Certificate of Designation designating 300,000 shares of our authorized preferred stock as Series D Participating Preferred Stock, par value $0.001 per share (the “Series D Participating Preferred Stock”). Each one one-thousandth of a share of Series D Participating Preferred Stock, if issued upon the exercise of the Rights, (i) will not be redeemable; (ii) will have the same voting power as one share of common stock and will vote together with the common stock; and (iii) will entitle holders to a payment per one one-thousandth of a share of Series D Participating Preferred Stock equal to the payment made on one share of common stock if the common stock is exchanged via merger, consolidation, or a similar transaction. Because of the nature of the Series D Participating Preferred Stock’s dividend, liquidation, and voting rights, the value of one one-thousandth of a share of Series D Participating Preferred Stock is expected to approximate the value of one share of common stock.

 

As of September 30, 2026 and December 31, 2025, there were 0 shares of Series A Convertible Preferred Stock outstanding. As of September 30, 2026 and December 31, 2025, there were 0 shares of Series B Preferred Stock outstanding. As of September 30, 2026 and December 31, 2025, there were 0 shares of Series C Preferred Stock outstanding. As of September 30, 2026 and December 31, 2025, there were 0 shares of Series D Participating Preferred Stock outstanding.

 

Treasury Stock

 

Upon vesting of restricted stock unit awards, employees may elect to have the Company withhold shares of common stock to cover their tax obligations, which are included as treasury stock outstanding and recorded within Treasury Stock on the condensed consolidated balance sheets. During the nine months ended September 30, 2026, no employees elected this option and accordingly no shares were withheld. During the nine months ended September 30, 2025, the Company withheld 404 shares of common stock with a cost of $293 to cover taxes owed by certain employees.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share of common stock (“EPS”) is calculated by dividing net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted EPS is calculated by dividing net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding, and the assumed exercise of all dilutive securities using the treasury stock method.

 

The 6,903,049 October 2025 Pre-Funded Warrants issued in the October Offerings and outstanding as of September 30, 2026 were included in the calculation of basic and diluted earnings (loss) per share.

 

The table below sets forth the Company’s calculated earnings (loss) per share, with net income (loss) presented in thousands:

               
    Three Months Ended September 30,   Nine Months Ended September 30,
    2026   2025   2026   2025
                 
Net Income (Loss) Attributable to Kartoon Studios, Inc.   $ (5,722 )   $ (6,570 )   $ 14,898     $ (19,259 )
Weighted-average shares of common stock outstanding     69,115,099       48,143,516       66,027,076       47,552,798  
Basic earnings (loss) per share   $ (0.08 )   $ (0.14 )   $ 0.23     $ (0.41 )
                                 
Net Income (Loss) Attributable to Kartoon Studios, Inc.   $ (5,722 )   $ (6,570 )   $ 14,898     $ (19,259 )
Weighted-average shares of common stock outstanding     69,115,099       48,143,516       66,027,076       47,552,798  
Effect of dilutive warrants and stock-based awards     –       –       3,116,186       –  
Weighted-average shares of common stock outstanding - diluted     69,115,099       48,143,516       69,143,262       47,552,798  
Diluted earnings (loss) per share   $ (0.08 )   $ (0.14 )   $ 0.22     $ (0.41 )

 

The following common stock equivalents were excluded from the calculation of diluted net earnings (loss) per share applicable to common stockholders, because including them would have had an anti-dilutive effect:

               
    Three Months Ended September 30,   Nine Months Ended September 30,
    2026   2025   2026   2025
Stock Options     839,998       973,980       839,998       973,980  
Restricted Stock Units     2,465,417       870,417       958,439       870,417  
Warrants     32,056,955       24,150,943       11,929,943       24,150,943  
      35,362,370       25,995,340       13,728,380       25,995,340